Aytekin Çıkman1, Mehmet Parlak2, Yasemin Bayram2, Hüseyin Güdücüoğlu2, Mustafa Berktaş3. 1. Mengucek Gazi Education and Research Hospital, Department of Medical Microbiology, Erzincan, Turkey. 2. Yuzuncu Yıl University Faculty of Medicine, Department of Medical Microbiology, Van, Turkey. 3. Lokman Hekim Hospital, Microbiology Laboratory, Van, Turkey.
Abstract
BACKGROUND: A limited number of antibiotics are recommended for the therapy of Stenotrophomonas maltophilia infections due to therapy difficulties caused by its numerous mechanisms of resistance. OBJECTIVES: In this study conducted over a period of approximately 5 years we aimed to determine resistance rates of S. maltophilia based on drug classification recommended by Clinical and Laboratory Standards Institute. METHODS: A total of 118 S. maltophilia strains isolated from various clinical specimens between January 2006 and June 2012 were included in the study. BD Phoenixautomated microbiology system (Becton Dickinson, USA) was utilized for species level identification and antibiotic susceptibility testing. RESULTS: Sixty seven of S. maltophilia strains were isolated from tracheal aspirate isolates, 17 from blood, 10 from sputum, 10 from wound and 14 from other clinical specimens. Levofloxacin was found to be the most effective antibiotic against S. maltophilia strains with resistance rate of 7.6%. The resistance rates to other antibiotics were as follows: chloramphenicol 18.2%, trimethoprim-sulfamethoxazole 20.3% and ceftazidime 72%. CONCLUSION: The study revealed that S. maltophilia is resistant to many antibiotics. The treatment of infections caused by S. maltophilia should be preferred primarily as levofloxacin, chloramphenicol, and TMP-SXT, respectively.
BACKGROUND: A limited number of antibiotics are recommended for the therapy of Stenotrophomonas maltophilia infections due to therapy difficulties caused by its numerous mechanisms of resistance. OBJECTIVES: In this study conducted over a period of approximately 5 years we aimed to determine resistance rates of S. maltophilia based on drug classification recommended by Clinical and Laboratory Standards Institute. METHODS: A total of 118 S. maltophilia strains isolated from various clinical specimens between January 2006 and June 2012 were included in the study. BD Phoenixautomated microbiology system (Becton Dickinson, USA) was utilized for species level identification and antibiotic susceptibility testing. RESULTS: Sixty seven of S. maltophilia strains were isolated from tracheal aspirate isolates, 17 from blood, 10 from sputum, 10 from wound and 14 from other clinical specimens. Levofloxacin was found to be the most effective antibiotic against S. maltophilia strains with resistance rate of 7.6%. The resistance rates to other antibiotics were as follows: chloramphenicol 18.2%, trimethoprim-sulfamethoxazole 20.3% and ceftazidime 72%. CONCLUSION: The study revealed that S. maltophilia is resistant to many antibiotics. The treatment of infections caused by S. maltophilia should be preferred primarily as levofloxacin, chloramphenicol, and TMP-SXT, respectively.
Authors: V Krcméry; P Sykora; J Trupl; A Kunova; A Sabo; L Jurga; J Novotny; F Mateicka; R Babela; E Pichnova; I M Gould Journal: J Chemother Date: 2001-04 Impact factor: 1.714
Authors: Francielly M W R Gos; Daiani C Savi; Khaled A Shaaban; Jon S Thorson; Rodrigo Aluizio; Yvelise M Possiede; Jürgen Rohr; Chirlei Glienke Journal: Front Microbiol Date: 2017-09-06 Impact factor: 5.640